FDA’s Dubious Honor: GAO Flags Many Of Its Activities As “High Risk”
Executive Summary
FDA's White Oak campus is still far from complete, but an extreme reading of official statements during the last few weeks might suggest that it could be closed
You may also be interested in...
FDA Stays In Hot Seat On Capitol Hill; PDUFA No Longer Drives Legislation
FDA operational problems will continue to be a prime target for congressional oversight, a House Republican staffer advised the Food and Drug Law Institute annual meeting April 23
FDA Stays In Hot Seat On Capitol Hill; PDUFA No Longer Drives Legislation
FDA operational problems will continue to be a prime target for congressional oversight, a House Republican staffer advised the Food and Drug Law Institute annual meeting April 23
Are Two Heads Better Than One? Not At FDA
Incoming FDA Commissioner Margaret Hamburg faces a number of regulatory challenges in her new role, but her first task may be establishing her singular leadership over the agency alongside a high profile deputy